San Antonio, TX - SABCS 2008 San Antonio Breast Cancer Symposium: Robert Coleman, M.D., professor of medical oncology at the University of Sheffield in the United Kingdom, addresses the Drugs in the Pipeline press conference on the study:?Abstract #5101. The addition of zoledronic acid to neoadjuvant chemotherapy may influence pathological response ? exploratory evidence for direct anti-tumor activity in breast cancer? at the 2008 San Antonio Breast Cancer Symposium here today, Thursday December 11, 2008. Over 8,000 Physicians, researchers and healthcare professionals from over 50 countries attended the meeting sponsored by American Association of Cancer Researchers (AACR) and the University of Texas, which features the latest research on Breast Cancer Treatment and Prevention. Date: Thursday December 11, 2008 Photo by © SABCS/Todd Buchanan 2008 Technical Questions: email@example.com; Phone: 612-226-5154.